NMOtion™ Blog
Discussing NMO Research and Advocacy
-
FDA Approves New Therapy from VielaBio for Neuromyelitis Optica Spectrum Disorder
-
2020 NMO Roundtable Conference and Patient Day Postponed
-
Press Release: FDA Accepts Genentech’s Biologics License Application for Satralizumab for Neuromyelitis Optica Spectrum Disorder
-
Genentech SAkuraStar Phase 3 Results
-
NYTimes: She Had Terrible Heartburn and Vomiting, but Her Problem Was Not in Her Stomach
-
Press Release: Alexion Receives FDA Approval Of SOLIRIS® (Eculizumab) For The Treatment Of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) Who Are Anti-Aquaporin-4 (AQP4) Antibody Positive
-
2018 Foundation Milestones
-
KCBS/A2A Spotlight Interview with Victoria Jackson
-
Chugai SAkuraSky Phase III Results
-
Alexion Prevent Phase 3 Results
-
The Guthy-Jackson Charitable Foundation Welcomes Christopher Clinton Conway as Executive Director
-
Young body builder battles rare autoimmune disorder
